Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Yelena Bisharyan
Advertisement
Yelena Bisharyan is research scientist I at the department of Microbiology & Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY
Articles by Yelena Bisharyan
Advertisement
Latest Updated Articles
An Alternative Platform for Rapid Production of Effective Subunit VaccinesPublished: October 2nd 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Challenges for Global Manufacturing of Vaccines
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
4
RNAnalytics’ Viktoria Enkmann Ponders Nanoparticle Characterization Advances at CPHI Frankfurt: Part One
5
